When the indication is reported as cell therapy (non-HCT) for the patient’s first event, or a post-HCT cell therapy is reported on an HCT follow-up form, the Cellular Therapy Pre-CTED Form 4000 will come due. Once completed and the data is processed, FormsNet3 will add additional forms based on whether the product was genetically modified and if the infusion was post-HCT.
The following sub-sections are available for Cell Therapy:
- Cell Therapy Training Resources
- CIBMTR Guidance Document for Reporting Autologous Cell Therapies
- Cell Therapy Reporting Preferences
- Cell Therapy Reporting Levels
- Cell Therapy Reporting Tracks and Follow-Up Schedules
- How Forms Come Due
- Combined Follow-Up Scenarios
- Common Cell Therapy Related Questions
Last modified:
Mar 25, 2025